Siren, L.L.C. Igm Biosciences, Inc. Transaction History
Siren, L.L.C.
- $2.26 Trillion
- Q4 2024
A detailed history of Siren, L.L.C. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 3,330,422 shares of IGMS stock, worth $4.46 Million. This represents 0.9% of its overall portfolio holdings.
Number of Shares
3,330,422
Previous 3,330,422
-0.0%
Holding current value
$4.46 Million
Previous $55.1 Billion
63.06%
% of portfolio
0.9%
Previous 2.75%
Shares
1 transactions
Others Institutions Holding IGMS
# of Institutions
86Shares Held
19.5MCall Options Held
61.3KPut Options Held
36.7K-
Baker Bros. Advisors LP New York, NY4.09MShares$5.49 Million0.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$4.78 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$3.96 Million1.41% of portfolio
-
Goldman Sachs Group Inc New York, NY978KShares$1.31 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA896KShares$1.2 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $38.8M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...